| Ongoing | 2 | 32 | Europe | AZD4017, AZD4017, Tablet | University of Oxford, Clinical Trials and Research Governance, Medical Research Council, AstraZeneca | Adverse effects of prescribed glucocorticoid therapy, Side effects of prescribed steroids, Body processes [G] - Metabolic Phenomena [G03] | | | | |
2017-001351-31: A study to assess the safety, rationale and effect of a new treatment to improve skin function and wound healing in patients with type 2 diabetes |
|
|
| Not yet recruiting | 2 | 30 | Europe | AZD4017, Tablet | University of Leeds, MRC Confidence in Concept Scheme | Type 2 diabetes, Diabetes, Diseases [C] - Nutritional and Metabolic Diseases [C18] | | | | |